Boston Scientific Thursday's IBD Stock Of The Day as the medtech trades just below all-time highs it hit late last month.

Boston Scientific BSX is gaining from new product launches and accretive acquisitions. Yet, unfavorable currency movement and ...

Boston Scientific Corp (BSX) stock saw a decline, ending the day at $94.88 which represents a decrease of $-1.07 or -1.12% from the prior close of $95.95. The stock opened at $95.48 and touched a low ...

Boston Scientific Corp (BSX) stock saw a modest uptick, ending the day at $95.95 which represents a slight increase of $3.96 or 4.30% from the prior close of $91.99. The stock opened at $96.68 and ...

Boston Scientific said the Intracept procedure was expected to generate over $100 million in sales in 2024. Relievant also was one of the biggest customers of the University of North Texas ...

Boston Scientific Corporation today announced it has entered into a definitive agreement to acquire Bolt Medical, Inc., the developer of an intravascular lithotripsy (IVL) advanced laser-based ...

Bernstein raised the firm’s price target on Boston Scientific (BSX) to $110 from $100 and keeps an Outperform rating on the shares as part of a ...

Boston Scientific (BSX) announced it has entered into a definitive agreement to acquire Bolt Medical, the developer of an intravascular lithotripsy advanced laser-based platform for the treatment ...

Patients already treated don’t need to do anything. Boston Scientific has updated its instructions for doctors using catheter technology to treat atrial fibrillation with extreme cooling ...

https://www.tipranks.com/news/company-announcements/nls-pharmaceutics-and-kadimastem-advance-merger-plans-with-500000-fundraising Truist raised the firm’s price ...